All Stories

  1. Obesity impairs leukocyte-endothelium cell interactions and oxidative stress in humans
  2. Involvement of insulin resistance in normoglycaemic obese patients with periodontitis: A cross-sectional study
  3. Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system
  4. Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial
  5. Atherosclerosis, Mitochondrial Dysfunction and Oxidative Stress: Mitochondria-Targeted Antioxidants as Potential Therapy
  6. Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients
  7. The consumption of a bread enriched with dietary fibre and l-carnitine improves glucose homoeostasis and insulin sensitivity in patients with metabolic syndrome
  8. Involvement of leucocyte/endothelial cell interactions in anorexia nervosa
  9. Validation of the Spanish version of the Problem Areas in Diabetes (PAID-SP) Scale
  10. Is Glycemic Control Modulating Endoplasmic Reticulum Stress in Leukocytes of Type 2 Diabetic Patients?
  11. Altered Mitochondrial Function and Oxidative Stress in Leukocytes of Anorexia Nervosa Patients
  12. Reply to “The association of red blood cell distribution width and morbid obesity” by Aydin et al.
  13. The role of reactive oxygen species in obesity therapeutics
  14. The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
  15. Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Protecting Endothelium in Cardiovascular Diseases
  16. Asociación de pravastatina y fenofibrato (Pravafenix®). Estudios de seguridad
  17. Red blood cell distribution width is not related with inflammatory parameters in morbidly obese patients
  18. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients
  19. Mitochondrial Impairment and Oxidative Stress in Leukocytes after Testosterone Administration to Female‐To‐Male Transsexuals
  20. Decálogo de recomendaciones clínicas en dislipidemia aterogénica
  21. Consenso de expertos sobre propuestas para la mejora del manejo de la dislipemia aterogénica
  22. Use of Expert Consensus to Improve Atherogenic Dyslipidemia Management
  23. Correction: Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
  24. Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
  25. Arteriopatía de las extremidades inferiores y estenosis de las arterias renales
  26. A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects
  27. Is Myeloperoxidase a Key Component in the ROS-Induced Vascular Damage Related to Nephropathy in Type 2 Diabetes?
  28. El hipotiroidismo subclínico, aspectos aún por dilucidar
  29. Mitochondrial Dysfunction and Oxidative Stress in Insulin Resistance
  30. Acute severe hyponatremia induced by aceclofen in a male patient with central diabetes insipidus
  31. Perspectives and Potential Applications of Mitochondria-Targeted Antioxidants in Cardiometabolic Diseases and Type 2 Diabetes
  32. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual
  33. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual
  34. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome
  35. Estudio de las subfracciones lipoproteicas tras el tratamiento de simvastatina y ezetimiba, en monoterapia o combinado, en pacientes hiperlipidémicos
  36. Fibratos: efectos farmacológicos
  37. Evidence for a relationship between mitochondrial Complex I activity and mitochondrial aldehyde dehydrogenase during nitroglycerin tolerance: Effects of mitochondrial antioxidants
  38. Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis
  39. Perfil lipídico residual en la cardiopatía isquémica recurrente
  40. Comparability of two different polyacrylamide gel electrophoresis methods for the classification of LDL pattern type
  41. A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
  42. Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
  43. Effect of weight loss on C3 and C4 components of complement in obese patients
  44. Induction of Oxidative Stress and Human Leukocyte/Endothelial Cell Interactions in Polycystic Ovary Syndrome Patients with Insulin Resistance
  45. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome
  46. Relationship Between Erectile Dysfunction and Silent Myocardial Ischemia in Type 2 Diabetic Patients with No Known Macrovascular Complications
  47. Oxidative Stress and its Clinical Consequences: Relationship between Diabetes and Cancer
  48. Mitochondrial Antioxidants Alleviate Oxidative and Nitrosative Stress in a Cellular Model of Sepsis
  49. Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
  50. Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo
  51. Prevalence of Metabolic Syndrome and its Components in Patients With Acute Coronary Syndrome
  52. Association between AT C573T polymorphism and cardiovascular risk factors in myocardial infarction
  53. Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients
  54. The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome
  55. Estudio REALIST (REsiduAl risk, LIpids and Standard Therapies): Un análisis del Riesgo Residual dependiente del perfil lipídico en el síndrome coronario agudo
  56. Distribución de la circunferencia de la cintura y de la relación circunferencia de la cintura con respecto a la talla según la categoría del índice de masa corporal en los pacientes atendidos en consultas de endocrinología y nutrición
  57. Seguridad de los análogos de insulina: qué evaluar, cómo hacerlo y cómo interpretar los resultados
  58. Mitochondria-Targeted Antioxidant Peptides
  59. Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols
  60. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual
  61. A Very High Prevalence of Low HDL Cholesterol in Spanish Patients With Acute Coronary Syndromes
  62. Effects of phytosterol ester-enriched low-fat milk on serum lipoprotein profile in mildly hypercholesterolaemic patients are not related to dietary cholesterol or saturated fat intake
  63. Testosterone Levels in Males with Type 2 Diabetes and Their Relationship with Cardiovascular Risk Factors and Cardiovascular Disease
  64. Cocientes lipoproteicos: significado fisiológico y utilidad clínica de los índices aterogénicos en prevención cardiovascular
  65. Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
  66. Mitochondrial-Targeted Antioxidants and Oxidative Stress: A Proteomic Prospective Study
  67. Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance
  68. A novel mutation in DAX1 (NR0B1) causing X-linked adrenal hypoplasia congenita: clinical, hormonal and genetic analysis
  69. Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants
  70. Activated protein C levels in obesity and weight loss influence
  71. Disfunción eréctil como marcador de vasculopatía en la diabetes mellitus tipo 2 en España. Estudio DIVA
  72. Erythrocyte Membrane Phosphatidylserine Exposure in Obesity
  73. Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene
  74. Obesity and overweight prevalences in rural and urban populations in East Spain and its association with undiagnosed hypertension and Diabetes Mellitus: a cross-sectional population-based survey
  75. Parameters of Inflammation in Morbid Obesity: Lack of Effect of Moderate Weight Loss
  76. The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus
  77. Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism
  78. Editorial
  79. Dislipemia del síndrome metabólico. Documento sumario del Foro-HDL
  80. Erythrocyte Hyperaggregation in Obesity: Determining Factors and Weight Loss Influence*
  81. Valor predictivo de la presión diferencial del pulso en el diagnóstico de isquemia miocárdica silente en pacientes con diabetes tipo 2
  82. Diabetes y embarazo. Guía Asistencial 2006
  83. Predictive Value of Differential Pulse Pressure in the Diagnosis of Silent Myocardial Ischemia in Patients With Type-2 Diabetes
  84. Management of Dyslipidemia in the Metabolic Syndrome
  85. Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio
  86. Cetoacidosis derivada del mal empleo de la pluma precargada de insulina detemir
  87. A rare missense mutation in a type 2 diabetes patient decreases the transcriptional activity of human sterol regulatory element binding protein-1
  88. Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients
  89. Metabolic Syndrome in Patients With Coronary Heart Disease. Results of Using Different Diagnostic Criteria
  90. Síndrome metabólico en pacientes con cardiopatía isquémica. Resultados obtenidos con la utilización de diferentes criterios
  91. Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention
  92. Rapid Onset of Wernicke's Encephalopathy following Gastric Restrictive Surgery
  93. Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica
  94. Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica
  95. Association between diabetic ketoacidosis and thyrotoxicosis
  96. Massive Triiodothyronine Intoxication: Efficacy of Hemoperfusion?
  97. Factores de riesgo cardiovascular en pacientes con obesidad mórbida: influencia de la pérdida de peso
  98. Prevalencia de malnutrición entre ancianos institucionalizados en la Comunidad Valenciana
  99. Effect of Thyroid Hormone Replacement on Lipoprotein(a), Lipids, and Apolipoproteins in Subjects With Hypothyroidism
  100. Contribution of Blood Flow to Leg Glucose Uptake During a Mixed Meal
  101. Efficacy and tolerability of miglitol in the treatment of patients with non—insulin-dependent diabetes mellitus